Wed, Apr 11, 2018
Akumin Inc. Announces US$35 Million Bought Deal
Toronto, Ontario – April 11, 2018 – Akumin Inc. (“Akumin” or the “Company”) (TSX: AKU.U) is pleased to announce that it has entered into an agreement with Clarus Securities Inc., on behalf of a syndicate of underwriters (collectively, the “Underwriters”), pursuant to which the Underwriters have agreed to purchase, on a “bought deal” basis, 8,750,000 Common Shares (the “Common Shares”) of the Company at a price of US$4.00 per Common Share (the “Offering Price”) for aggregate gross proceeds to the Company of US$35,000,000 (the “Offering”).

Thu, Apr 5, 2018
Akumin Secures Rights for Potential Acquisition of Four Centers with US$12 Million in Revenues
April 5, 2018 – Toronto, ON – Akumin Inc. (TSX:AKU.U) (the “Company” or “Akumin”) announced today that it has entered into a management agreement with the owners of four centers located in one of Akumin’s core geographic markets (the “Potential Acquisition”).

Mon, Apr 2, 2018
Akumin Inc. Announces Fiscal 2017 Financial Results
TORONTO, April 2, 2018 /CNW/ – Akumin Inc. (TSX:AKU.U) (“Akumin” or the “Corporation”) announced today its financial results for the quarter ended December 31, 2017 (“December 2017 Quarter”) and the fifteen-month period ended December 31, 2017 (“Fiscal 2017”).

Mon, Mar 26, 2018
Akumin Inc. Enters Into Agreements to Acquire Non-Controlling Interests for $21.3 million
Akumin Inc. (TSX:AKU.U) (the “Company” or “Akumin”) announced today that its wholly owned subsidiary, Preferred Medical Imaging, LLC,  has entered into agreements to acquire all of the outstanding non-controlling interests in seven of its existing Texas-based diagnostic imaging centers (the “Acquisitions”).

Fri, Feb 9, 2018
Akumin Inc. Announces Purchase of Approximately US$1.9 Million in Shares by Certain Officers and Directors
Akumin Inc. (TSX:AKU.U) (the “Company“) announced today that certain senior officers and directors of the Company have acquired an aggregate of 532,857 shares of the Company at US$3.50 per share for total cash consideration of approximately US$1,865,000.